NCT01059903View on ClinicalTrials.gov

Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Rotigotine transdermal patch

Rotigotine 4.5 mg/10 cm\^2 patch applied for 24 hours

Trial Locations (1)

Unknown

Mönchengladbach

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY